AI
EBS icon

Ariel Investments’s Emergent Biosolutions EBS Stock Holding History

Ariel Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-122,650
Closed -$2.82M – 185
2013
Q4 		$2.82M Buy
122,650
+63,050
+106% +$1.31M 0.03% 155
2013
Q3 		$1.14M Buy
59,600
+32,100
+117% +$573K 0.02% 145
2013
Q2 		$397K Buy
+27,500
New +$398K 0.01% 136

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ariel Investments's EBS Position: Q1 2014 in Review

Ariel Investments sold out of Emergent Biosolutions (EBS) in Q1 2014, closing a stake of 122,650 shares — an estimated $2.82M sold.

Ariel Investments first reported a position in EBS in Q2 2013 and held it in 3 quarters. The position peaked at $2.82M in Q4 2013. 168 funds tracked by Wall St. Rank hold EBS as of Q1 2014.

  • Ariel Investments reported no remaining Emergent Biosolutions position as of Q1 2014 after selling out during the quarter.
  • Ariel Investments sold 122,650 Emergent Biosolutions shares in Q1 2014, an estimated $2.82M.
  • Ariel Investments first reported a position in Emergent Biosolutions in Q2 2013 and held it in 3 quarters.
  • Ariel Investments's Emergent Biosolutions position peaked at $2.82M in Q4 2013.
  • 168 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2014.

Based on Ariel Investments's 13F filing for Q1 2014, filed 14 May 2014.